UKHIFU - High Intensity Focused Ultrasound contact us  
Text Size: Small Text Medium Text Large Text








April 17, 2012
Lancet Oncology Study
Study shows significant side effect reduction with HIFU to treat prostate cancer... more >


Sky News, April 17, 2012
Prostate Cancer Treatment 'Reduces Side Effects'
A high-powered beam of ultrasound can destroy prostate cancer without causing the serious side effects... more >


Urology Times, May 1, 2012
Data show low morbidity of HIFU in short-term trials
Technique appears safe, but evaluation of efficacy awaits longer-term data... more >

Have you or a member of your family been diagnosed with prostate cancer?



High intensity focused ultrasound, or HIFU, is a minimally invasive therapy option for localised prostate cancer that may offer a balance between eliminating cancer and maintaining quality of life. The Sonablate® 500 (“Sonablate”) uses precisely focused ultrasound waves that, when delivered, raise the temperature of the targeted prostate tissue to 80-90 degrees Celsius in 2-3 seconds. This rapid-firing heat destroys the targeted tissue while leaving healthy structures outside the prostate gland unharmed.

UKHIFU, Limited (“UK HIFU”), a subsidiary of USHIFU, LLC, is the London-based European distributor of the Sonablate medical device. UK HIFU is committed to treating prostate cancer using HIFU with the Sonablate 500, a minimally invasive, outpatient procedure pioneered to control cancer and significantly improve patients’ quality of life. The Sonablate HIFU procedure is available in almost 20 hospitals throughout the United Kingdom.

This website explores the Sonablate HIFU procedure for prostate cancer patients located within the United Kingdom. Inside you will learn more about the procedure, where it is available and if you qualify.

This site complies to the HONcode standard for trustworthy health information: verify here


Copyright © 2013 UKHIFU | All rights reserved